[1]树叶,黄文雅,罗勇奇,等.10例婴幼儿卡梅综合征临床特征及治疗经验总结[J].临床小儿外科杂志,2019,18(09):775-778.[doi:10.3969/j.issn.1671-6353.2019.09.014]
 Shu Ye,Huang Wenya,Luo Yongqi,et al.Summary of clinical features and treatment protocols of 10 infants with Kasabach-Merritt syndrome[J].Journal of Clinical Pediatric Surgery,2019,18(09):775-778.[doi:10.3969/j.issn.1671-6353.2019.09.014]
点击复制

10例婴幼儿卡梅综合征临床特征及治疗经验总结

参考文献/References:

1 Dasgupta R,Fishman SJ.ISSVA classification[J].Semin Pediatr Surg,2014,23(4):158-161.DOI:10.1053/j.sempedsurg.2014.06.016.
2 Fernandez Y,Bernabeu-Wittel M,Garcia-Morillo JS.Kaposiform hemangioendothelioma[J].Eur J Intern Med,2009,20(2):106-113.DOI:10.1016/j.ejim.2008.06.008.
3 廖清奎.血液病基础与临床[M].北京:人民卫生出版社,2001:702-703. Liao QK.Basic and Clinical Hematology[M].Beijing:People’s Medical Publishing House,2001:702-703.
4 夏红萍,何正娟,朱建幸,等.卡-梅综合征10例临床分析[J].中国实用儿科杂志,2011,26(2):125-127. Xia HP,He ZJ,Zhu JX,et al.Clinical analysis of 10 cases with Kasabach-Merritt syndrome[J].Chinese Journal of Practical Pediatrics,2011,26(2):125-127.
5 Drolet BA,Brandao LR,Chiu YE,et al.Consensus-derived practice standards plan for complicated Kaposiforrn hemangioendothelioma[J].J Pediatr,2013,163(1):285-291.DOI:10.1016/j.jpeds.2013.03.080.
6 Kim T,Roh MR,Cho S,et al.Kasabach-merritt syndrome arising from tufted angioma successfully treated with systemic corticosteroid[J].Ann Dermatol,2010,22(4):426-430.DOI:10.5021/ad.2010.22.4.426.
7 Jiang RS,Hu IL.Successful treatment of Kasabach Merritt syndrome arising from kaposiform hemangioendothelioma by systemic corticosteroid therapy and surgery[J].Int J Clin Oncol,2012,17(5):512-516.DOI:10.1007/s10147-011-0321-4.
8 Tan X,Chen M,Zhang J,et al.Treatment of corticosteroid-resistant vascular tumors associated with the Kasabach-Merritt phenomenon in infants:an approach with transcather arterial emblization plus vincristine therapy[J].J Vasc Interv Radiol,2016,27(4):569-575.DOI:10.1016/j.jvir.2015.12.012.
9 Wang Z,Li K,Yao W,et al.Steroid-resistant kaposiform hemangioendothelioma:A retrospective study of 37 patients treated with vincristine and long-term follow-up[J].Pediatr Blood Cancer,2015,62(4):577-580.DOI:10.1002/pbc.25296.
10 Fahrtash F,Mccahon E,Arbuckle S.Successful treatment of kaposifon hemangioendothelioma and tufted angioma with vincristine[J].J Pediatr Hematol Oncol,2010,32(6):506-510.DOI:10.1097/MPH.0b013e3181e001a9.
11 孙艳纯,郑姗,李凯,等.长春新碱治疗血管瘤伴血小板减少综合征的疗效探讨[J].临床小儿外科杂志,2009,8(5):3-5.DOI:10.3969/j.issn.1671-6353.2009.05.002. Sun YC,Zheng S,Li K,et al.Initial experience of treatment of Kasabach-Merritt syndrome with vincristine[J].J Clin Ped Sur,2009,8(5):3-5.DOI:10.3969/j.issn.1671-6353.2009.05.002.
12 Mora E,Smith EM,Donohoe C,et al.Vineristine-induced peripheral neuropathy in pediatric cancer patients[J].Am J Cancer Res,2016,6(11):2416-2430.

相似文献/References:

[1]周启星,杨文,成琦,等.婴儿腮腺血管瘤22例[J].临床小儿外科杂志,2007,6(03):17.
[2]杨恩 刘铭 彭强. 血管瘤血管内皮生长因子受体KDR基因异常甲基化的研究[J].临床小儿外科杂志,2012,11(04):268.
 [J].Journal of Clinical Pediatric Surgery,2012,11(09):268.
[3]徐仙赟 谢琼珺 黄海金. 噻吗洛尔和普萘洛尔体外调控小鼠血管瘤细胞增殖及凋亡作用的比较[J].临床小儿外科杂志,2014,13(02):117.
[4]黄文雅 肖 天 李春旺 邓 敏 金 科.血管瘤并血小板减少综合征介入栓塞治疗的效果分析[J].临床小儿外科杂志,2018,17(01):43.
 Huang Wenya,Xiao Tian,Li Chunwang,et al.Interventional treatment for KasabachMerrit syndrome in children:a report of 7 cases.[J].Journal of Clinical Pediatric Surgery,2018,17(09):43.
[5]高石,赵国强,岳晓洁.儿童指端血管球瘤1例报道并文献复习[J].临床小儿外科杂志,2019,18(07):615.[doi:10.3969/j.issn.1671-6353.2019.07.019]
 Gao Shi,Zhao Guoqiang,Yue Xiaojie.A case report of a fingertip glomus tumor in children and literature review[J].Journal of Clinical Pediatric Surgery,2019,18(09):615.[doi:10.3969/j.issn.1671-6353.2019.07.019]
[6]刘文英.脉管异常类疾病的分类及相关临床问题[J].临床小儿外科杂志,2019,18(08):621.[doi:10.3969/j.issn.1671-6353.2019.08.001]
 Liu Wenying.Classifications and clinical managements of vascular abnormalities[J].Journal of Clinical Pediatric Surgery,2019,18(09):621.[doi:10.3969/j.issn.1671-6353.2019.08.001]
[7]王川,李亚楠,向波,等.婴幼儿血管瘤生活质量专用量表的信度与效度检验及其临床应用[J].临床小儿外科杂志,2019,18(08):635.[doi:10.3969/j.issn.1671-6353.2019.08.004]
 Wang Chuan,Li Yanan,Xiang Bo,et al.Measuring reliability and validity of a Chinese mandarin version quality-of-life instrument for infantile hemangioma and its clinical application[J].Journal of Clinical Pediatric Surgery,2019,18(09):635.[doi:10.3969/j.issn.1671-6353.2019.08.004]
[8]张明,彭强,刘铭.NF-κB因子在普萘洛尔治疗裸鼠血管瘤模型过程中的表达[J].临床小儿外科杂志,2019,18(08):655.[doi:10.3969/j.issn.1671-6353.2019.08.008]
 Zhang Ming,Peng Qiang,Liu Ming.Expression of NF-kappa B in propranolol treatment for infantile hemangioma in nude mice model[J].Journal of Clinical Pediatric Surgery,2019,18(09):655.[doi:10.3969/j.issn.1671-6353.2019.08.008]
[9]王长凤,孙佳丽,吴长华,等.595 nm脉冲染料激光联合噻吗洛尔滴眼液治疗浅表性婴幼儿血管瘤的疗效观察[J].临床小儿外科杂志,2019,18(11):953.[doi:10.3969/j.issn.1671—6353.2019.11.011]
 Wang Changfeng,Sun Jiali,Wu Changhua,et al.Curative efficacy of timolol plus 595nm pulsed dye laser for superficial infantile hemangioma[J].Journal of Clinical Pediatric Surgery,2019,18(09):953.[doi:10.3969/j.issn.1671—6353.2019.11.011]
[10]王怀杰,谢崇,蔺卫龙,等.纤维脂肪血管病变13例的诊断与治疗[J].临床小儿外科杂志,2022,21(07):668.[doi:10.3760/cma.j.cn101785-202102022-014]
 Wang Huaijie,Xie Chong,Lin Weilong,et al.Diagnosis and treatment of fibro-adipose vascular anomaly(FAVA)[J].Journal of Clinical Pediatric Surgery,2022,21(09):668.[doi:10.3760/cma.j.cn101785-202102022-014]

备注/Memo

收稿日期:2018-10-19。
基金项目:湖南省医药卫生科研计划项目(编号:B2016039)
通讯作者:汤建萍,Email:jpingtang@126.com

更新日期/Last Update: 1900-01-01